The goal of this pilot randomized controlled trial with economic evaluation is to evaluate the viability of Pilates in the prevention of musculoskeletal complaints, throughout the entire gestational period, in pregnant women. The main question it aims to answer is if it is feasible to perform exercises during the entire gestational period to prevent musculoskeletal disorders. Participants will be assessed primarily for acceptability, suitability, feasibility, and fidelity, and secondarily for the occurrence of musculoskeletal complaint and the number of days from randomization on which this musculoskeletal complaint occurred, type of delivery and costs. Then, participants will be randomized into two groups: the usual care group, which will receive an educational booklet with information about the usual care during pregnancy, and the Pilates group, which will receive the same educational booklet and will participate in a specific Pilates exercise program for the gestational period, twice a week, throughout the pregnancy.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Enrollment
20
Sessions will last 60 minutes: five minutes for warming up, 50 minutes for the practice of Pilates exercises, and five minutes for relaxing with the Swiss ball. The exercise protocol will be divided into three gestational phases, covering the entire gestational period, with different and specific objectives for each phase. In all phases, the exercises will be classified into three levels of difficulty: basic, intermediate, and advanced, according to the evolution of each pregnant woman throughout the practice of Pilates. Modifications will be allowed to facilitate or hinder the execution of the movement. The exercises will be performed in one or two sets of seven to 10 repetitions. The number of series, repetitions and exercises and interval time between them, as well as the level of difficulty of the exercises, will be gradually adjusted. The intensity of the exercises will vary between light and moderate and will be controlled by the Borg scale.
Acceptability measured using a 11-point numerical scale (0 = completely dissatisfied with the treatment results; 10 = completely satisfied with the treatment results)
The participant's perception of the treatment result being satisfactory
Time frame: 24th gestational week
Acceptability measured using a 11-point numerical scale (0 = completely dissatisfied with the treatment results; 10 = completely satisfied with the treatment results)
The participant's perception of the treatment result being satisfactory
Time frame: 36th gestational week
Acceptability measured using a 11-point numerical scale (0 = completely dissatisfied with the treatment results; 10 = completely satisfied with the treatment results)
The participant's perception of the treatment result being satisfactory
Time frame: From 7 to 15 days after delivery
Suitability measured using 2 questions (one about the need of tailored exercises for the gestational needs and the other about the need of some adaptation during the execution of the exercises)
Assesses whether the exercise program is suitable for the target audience or needs some adaptation
Time frame: 24th gestational week
Suitability measured using 2 questions (one about the need of tailored exercises for the gestational needs and the other about the need of some adaptation during the execution of the exercises)
Assesses whether the exercise program is suitable for the target audience or needs some adaptation
Time frame: 36th gestational week
Suitability measured using 2 questions (one about the need of tailored exercises for the gestational needs and the other about the need of some adaptation during the execution of the exercises)
Assesses whether the exercise program is suitable for the target audience or needs some adaptation
Time frame: From 7 to 15 days after delivery
Viability measured using a form developed for this study and filled by the physical therapist responsible for the treatment
Assesses recruitment, retention, and participation rates, whether participants reached the end of the treatment program and, if not, why they dropped out
Time frame: 24th gestational week
Viability measured using a form developed for this study and filled by the physical therapist responsible for the treatment
Assesses recruitment, retention, and participation rates, whether participants reached the end of the treatment program and, if not, why they dropped out
Time frame: 36th gestational week
Viability measured using a form developed for this study and filled by the physical therapist responsible for the treatment
Assesses recruitment, retention, and participation rates, whether participants reached the end of the treatment program and, if not, why they dropped out
Time frame: From 7 to 15 days after delivery
Fidelity measured using an exercise checklist (list of all exercises that can be performed including the level of difficulty)
Assesses the level of difficulty of the selected exercises
Time frame: 24th gestational week
Fidelity measured using an exercise checklist (list of all exercises that can be performed including the level of difficulty)
Assesses the level of difficulty of the selected exercises
Time frame: 36th gestational week
Fidelity measured using an exercise checklist (list of all exercises that can be performed including the level of difficulty)
Assesses the level of difficulty of the selected exercises
Time frame: From 7 to 15 days after delivery
Occurrence of musculoskeletal complaint
Time frame: 24th gestational week, 36th gestational week, and from seven to 15 days after delivery
Number of days from randomization on which the musculoskeletal complaint occurred
Time frame: 24th gestational week, 36th gestational week, and from seven to 15 days after delivery
Delivery mode (normal or caesarean section)
Time frame: From 7 to 15 days after delivery
Apgar score (0 to 10)
Reported at 1 minute and 5 minutes after birth, and at 5-minute intervals thereafter until 20 minutes for infants with a score less than 7
Time frame: From 7 to 15 days after delivery
Baby's birth weight
Time frame: From 7 to 15 days after delivery
Kinesiophobia measured using the Tampa Scale of Kinesiophobia in the occurrence of musculoskeletal complaint
The total score ranges from 17 to 68 points, and the higher the score, the greater the degree of kinesiophobia.
Time frame: 24th gestational week, 36th gestational week, and from 7 to 15 days after delivery
Disability measured using the Patient Specific Functional Scale in the occurrence of musculoskeletal complaint
11-point numerical scale (0 = unable to perform the activity; 10 = able to perform the activity at the same level as before the injury or problem)
Time frame: 24th gestational week, 36th gestational week, and from 7 to 15 days after delivery
Pain measured using the Pain Numerical Rating Scale in the occurrence of musculoskeletal complaint
11-point numerical scale (0 = no pain; 10 = the worst possible pain)
Time frame: 24th gestational week, 36th gestational week, and from 7 to 15 days after delivery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Costs (healthcare costs, patient and family costs, and lost productivity costs) measured using a questionnaire specially developed for this study
Time frame: Baseline, 24th gestational week, 36th gestational week, and from 7 to 15 days after delivery